Barclays Maintains Equal-Weight on Sabra Health Care REIT, Raises Price Target to $23

Benzinga · 2d ago
Barclays analyst Richard Hightower maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Equal-Weight and raises the price target from $21 to $23.